Synonym
Arsphenamine; X 109; X109; X-109
IUPAC/Chemical Name
2-amino-4-(3-amino-4-hydroxyphenyl)arsanylidenearsanylphenol;dihydrochloride
InChi Key
VLAXZGHHBIJLAD-UHFFFAOYSA-N
InChi Code
InChI=1S/C12H12As2N2O2.2ClH/c15-9-5-7(1-3-11(9)17)13-14-8-2-4-12(18)10(16)6-8;;/h1-6,17-18H,15-16H2;2*1H
SMILES Code
OC1=CC=C(/[As]=[As]/C2=CC=C(O)C(N)=C2)C=C1N.[H]Cl.[H]Cl
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
439.00
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Vernon G. Syphilis and Salvarsan. Br J Gen Pract. 2019 May;69(682):246. doi: 10.3399/bjgp19X702533. PubMed PMID: 31023681; PubMed Central PMCID: PMC6478456.
2: Ros-Vivancos C, González-Hernández M, Navarro-Gracia JF, Sánchez-Payá J, González-Torga A, Portilla-Sogorb J. [Evolution of treatment of syphilis through history]. Rev Esp Quimioter. 2018 Dec;31(6):485-492. Epub 2018 Nov 14. Review. Spanish. PubMed PMID: 30427145; PubMed Central PMCID: PMC6254479.
3: Stekel D. First report of antimicrobial resistance pre-dates penicillin. Nature. 2018 Oct;562(7726):192. doi: 10.1038/d41586-018-06983-0. PubMed PMID: 30305753.
4: Warner VD, Soloway AH. Infections caused by resistant organisms: Could organic arsenic compounds be an effective treatment? Med Hypotheses. 2017 Jul;104:78-79. doi: 10.1016/j.mehy.2017.05.026. Epub 2017 May 26. PubMed PMID: 28673597.
5: Gupta N, Rodrigues C, Soman R. Pioneers in Antimicrobial Chemotherapy. J Assoc Physicians India. 2015 Sep;63(9):90-1. PubMed PMID: 27608881.
6: Tsiamis C, Vrioni G, Poulakou-Rebelakou E, Gennimata V, Murdjeva MА, Tsakris A. Medical and Social Aspects of Syphilis in the Balkans from the mid-19th Century to the Interwar. Folia Med (Plovdiv). 2016 Mar 1;58(1):5-11. doi: 10.1515/folmed-2016-0001. Review. PubMed PMID: 27383872.
7: Bonnichon P, Berger JP, Bonni N, Fontaine M, Pion-Graff J. [History of cancer and chemotherapy before chemotherapy]. Hist Sci Med. 2014 Oct-Dec;48(4):469-74. French. PubMed PMID: 25962214.
8: Bernhardt M. Hoffman's drops: the technique of the concentrated neosalvarsan injection. Skinmed. 2015 Jan-Feb;13(1):65. PubMed PMID: 25842475.
9: Gelpi A, Tucker JD. The magic bullet hits many targets: Salvarsan's impact on UK health systems, 1909-1943. Sex Transm Infect. 2015 Feb;91(1):69-70. doi: 10.1136/sextrans-2014-051780. PubMed PMID: 25609468; PubMed Central PMCID: PMC4317402.
10: Gelpi A, Gilbertson A, Tucker JD. Magic bullet: Paul Ehrlich, Salvarsan and the birth of venereology. Sex Transm Infect. 2015 Feb;91(1):68-9. doi: 10.1136/sextrans-2014-051779. PubMed PMID: 25609467; PubMed Central PMCID: PMC4318855.
11: Gelpi A, Tucker JD. After Venus, mercury: syphilis treatment in the UK before Salvarsan. Sex Transm Infect. 2015 Feb;91(1):68. doi: 10.1136/sextrans-2014-051778. PubMed PMID: 25609466; PubMed Central PMCID: PMC4317394.
12: Ferrie JE. Arsenic, antibiotics and interventions. Int J Epidemiol. 2014 Aug;43(4):977-82. PubMed PMID: 25237690; PubMed Central PMCID: PMC4258791.
13: Dufty NE, Leverton D. The treatment of syphilis with salvarsan. J R Army Med Corps. 2014 Jun;160 Suppl 1:i21-3. doi: 10.1136/jramc-2014-000288. PubMed PMID: 24845891.
14: Sekhon BS. Metalloid compounds as drugs. Res Pharm Sci. 2013 Jul;8(3):145-58. Review. PubMed PMID: 24019824; PubMed Central PMCID: PMC3764666.
15: Beneš J. [Dawn of the antibiotic era and some consequences for the present]. Klin Mikrobiol Infekc Lek. 2012 Oct;18(5):142-9. Review. Czech. PubMed PMID: 23208868.
16: Zaffiri L, Gardner J, Toledo-Pereyra LH. History of antibiotics. From salvarsan to cephalosporins. J Invest Surg. 2012 Apr;25(2):67-77. doi: 10.3109/08941939.2012.664099. Review. PubMed PMID: 22439833.
17: Cooper D. The licensing of German drug patents confiscated during World War I: federal and private efforts to maintain control, promote production, and protect public health. Pharm Hist. 2012;54(1):3-32. PubMed PMID: 24620480.
18: Lautenschlager S. [Syphilis 1923 - 1924 - a contribution from 1924 and comment from the current status]. Praxis (Bern 1994). 2011 Aug 24;100(17):1019-23. doi: 10.1024/1661-8157/a000635. German. PubMed PMID: 21863571.
19: Sepkowitz KA. One hundred years of Salvarsan. N Engl J Med. 2011 Jul 28;365(4):291-3. doi: 10.1056/NEJMp1105345. PubMed PMID: 21793743.
20: Neu HC, Gootz TD. Antimicrobial Chemotherapy. In: Baron S, editor. Medical Microbiology. 4th edition. Galveston (TX): University of Texas Medical Branch at Galveston; 1996. Chapter 11. PubMed PMID: 21413283.
